RET and medullary thyroid gland carcinoma: The 2009 ATA guidance adopted classes A through D (with D as the most severe); in the 2015 revisions, they were updated to “moderate”, “high” and “highest” risk of MTC, with accordant guidance on timing of prophylactic thyroidectomy for unaffected RET mutation carriers (Table 1) (6, 7).